Skip to Main content Skip to Navigation
Patents

Utilisation d'élements de régulation négative pour l'expression neurospécifique de transgènes

Abstract : The invention concerns novel methods and constructs for controlling nucleic acid expression, in particular methods and constructs using NRSE sequences for obtaining a targeted expression of transgenes in the nerve cells in vivo or ex vivo. The invention is particularly adapted for in vivo gene transfer applications, for instance for therapeutic or scientific approach.
Document type :
Patents
Complete list of metadata

https://hal.inrae.fr/hal-02841615
Contributor : Migration ProdInra Connect in order to contact the contributor
Submitted on : Sunday, June 7, 2020 - 3:00:49 PM
Last modification on : Wednesday, May 5, 2021 - 12:00:02 PM

Identifiers

  • HAL Id : hal-02841615, version 1
  • PRODINRA : 322150

Collections

Citation

Hélène Kiefer, Jacques Mallet, Stéphanie Millecamps. Utilisation d'élements de régulation négative pour l'expression neurospécifique de transgènes. N° de brevet: WOFR9900061. 1999. ⟨hal-02841615⟩

Share

Metrics

Record views

6